Therapeutics Letter 36, July / August 2000: Tolterodine (Detrol®)
Approved indication: Relief of symptoms in patients with overactive bladder, defined as increased urinary frequency (> 7/day) plus urgency and/or urge incontinence.
http://www.ti.ubc.ca/pages/letter36.htm#Tolterodine
Esta web está
dirigida únicamente a profesionales sanitarios.
Web de tipo personal no ligada
a ninguna entidad pública ni privada | Quiénes
somos |
INFOMEDICAMENTO.NET - España -
2010.